Stock Events

Stock Events

Search...

Madrigal Pharmaceuticals (MDGL) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-6.75

-5.13

-3.52

-1.9

Details

Expected EPS

-3.554232

Actual EPS

-1.9

Surprise EPS

1.65

Surprise Percent

+46.54%

Description

Madrigal Pharmaceuticals (MDGL) has reported earnings of -1.9 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.